Systems Biology Approach for Cancer Vaccine Development and Evaluation

Therapeutic cancer vaccines do not hold promise yet as an effective anti-cancer treatment. Lack of efficacy or poor clinical outcomes are due to several antigenic and immunological aspects that need to be addressed in order to reverse such trends and significantly improve cancer vaccines’ efficacy....

Full description

Bibliographic Details
Main Authors: Luisa Circelli, Annacarmen Petrizzo, Maria Tagliamonte, Maria Lina Tornesello, Franco M. Buonaguro, Luigi Buonaguro
Format: Article
Language:English
Published: MDPI AG 2015-07-01
Series:Vaccines
Subjects:
Online Access:http://www.mdpi.com/2076-393X/3/3/544
id doaj-dc0e5516e3e94e6c93f83872e617092c
record_format Article
spelling doaj-dc0e5516e3e94e6c93f83872e617092c2020-11-24T22:30:49ZengMDPI AGVaccines2076-393X2015-07-013354455510.3390/vaccines3030544vaccines3030544Systems Biology Approach for Cancer Vaccine Development and EvaluationLuisa Circelli0Annacarmen Petrizzo1Maria Tagliamonte2Maria Lina Tornesello3Franco M. Buonaguro4Luigi Buonaguro5Laboratory of Molecular Biology and Viral Oncology, Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, "Fondazione Pascale" - IRCCS, Naples 80131, ItalyLaboratory of Molecular Biology and Viral Oncology, Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, "Fondazione Pascale" - IRCCS, Naples 80131, ItalyLaboratory of Molecular Biology and Viral Oncology, Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, "Fondazione Pascale" - IRCCS, Naples 80131, ItalyLaboratory of Molecular Biology and Viral Oncology, Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, "Fondazione Pascale" - IRCCS, Naples 80131, ItalyLaboratory of Molecular Biology and Viral Oncology, Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, "Fondazione Pascale" - IRCCS, Naples 80131, ItalyLaboratory of Molecular Biology and Viral Oncology, Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, "Fondazione Pascale" - IRCCS, Naples 80131, ItalyTherapeutic cancer vaccines do not hold promise yet as an effective anti-cancer treatment. Lack of efficacy or poor clinical outcomes are due to several antigenic and immunological aspects that need to be addressed in order to reverse such trends and significantly improve cancer vaccines’ efficacy. The newly developed high throughput technologies and computational tools are instrumental to this aim allowing the identification of more specific antigens and the comprehensive analysis of the innate and adaptive immunities. Here, we review the potentiality of systems biology in providing novel insights in the mechanisms of the action of vaccines to improve their design and effectiveness.http://www.mdpi.com/2076-393X/3/3/544systems vaccinologycancer vaccinecancer immunotherapy
collection DOAJ
language English
format Article
sources DOAJ
author Luisa Circelli
Annacarmen Petrizzo
Maria Tagliamonte
Maria Lina Tornesello
Franco M. Buonaguro
Luigi Buonaguro
spellingShingle Luisa Circelli
Annacarmen Petrizzo
Maria Tagliamonte
Maria Lina Tornesello
Franco M. Buonaguro
Luigi Buonaguro
Systems Biology Approach for Cancer Vaccine Development and Evaluation
Vaccines
systems vaccinology
cancer vaccine
cancer immunotherapy
author_facet Luisa Circelli
Annacarmen Petrizzo
Maria Tagliamonte
Maria Lina Tornesello
Franco M. Buonaguro
Luigi Buonaguro
author_sort Luisa Circelli
title Systems Biology Approach for Cancer Vaccine Development and Evaluation
title_short Systems Biology Approach for Cancer Vaccine Development and Evaluation
title_full Systems Biology Approach for Cancer Vaccine Development and Evaluation
title_fullStr Systems Biology Approach for Cancer Vaccine Development and Evaluation
title_full_unstemmed Systems Biology Approach for Cancer Vaccine Development and Evaluation
title_sort systems biology approach for cancer vaccine development and evaluation
publisher MDPI AG
series Vaccines
issn 2076-393X
publishDate 2015-07-01
description Therapeutic cancer vaccines do not hold promise yet as an effective anti-cancer treatment. Lack of efficacy or poor clinical outcomes are due to several antigenic and immunological aspects that need to be addressed in order to reverse such trends and significantly improve cancer vaccines’ efficacy. The newly developed high throughput technologies and computational tools are instrumental to this aim allowing the identification of more specific antigens and the comprehensive analysis of the innate and adaptive immunities. Here, we review the potentiality of systems biology in providing novel insights in the mechanisms of the action of vaccines to improve their design and effectiveness.
topic systems vaccinology
cancer vaccine
cancer immunotherapy
url http://www.mdpi.com/2076-393X/3/3/544
work_keys_str_mv AT luisacircelli systemsbiologyapproachforcancervaccinedevelopmentandevaluation
AT annacarmenpetrizzo systemsbiologyapproachforcancervaccinedevelopmentandevaluation
AT mariatagliamonte systemsbiologyapproachforcancervaccinedevelopmentandevaluation
AT marialinatornesello systemsbiologyapproachforcancervaccinedevelopmentandevaluation
AT francombuonaguro systemsbiologyapproachforcancervaccinedevelopmentandevaluation
AT luigibuonaguro systemsbiologyapproachforcancervaccinedevelopmentandevaluation
_version_ 1725739175382089728